Literature DB >> 6115787

Evidence for the hormonal status of somatostatin in man.

E S Zyznar, A O Pietri, V Harris, R H Unger.   

Abstract

To determine the hormonal status of somatostatin in man, plasma levels of approximately 1600-dalton somatostatin-like immunoreactivity (SLI) were measured before and after a mixed meal. Plasma was subjected to gel filtration and the fractions coeluting with somatostatin were concentrated ninefold before radioimmunoassay. In this system the recovery of synthetic somatostatin added to plasma averaged 71 +/- 4.6% (mean +/- SE, N = 5). Synthetic somatostatin infused into normal volunteers gave a dose-related increase in the measured SLI value. Fasting SLI in 13 normal volunteers was 8.0 +/- 0.7 pg/ml (mean +/- SE) and rose to 18.6 +/- 1.5 pg/ml and 20.3 +/- 2.0 pg/ml at 60 and 120 min, respectively, after the meal (P less than 0.001). In seven type I diabetics, the fasting level was 11.5 +/- 1.6 pg/ml and the 60- and 120-min postprandial levels were 21.4 +/- 2.5 and 22.3 +/- 2.9 pg/ml, respectively. The meal-induced rise in approximately 1600 M.W. SLI approximated that produced by infusing somatostatin at 2 microgram/h, a rate that significantly suppressed glucagon levels. These results are therefore consistent with a hormonal role for somatostatin in man.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6115787     DOI: 10.2337/diab.30.10.883

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  12 in total

1.  A unique control mechanism in the regulation of insulin secretion. Secretagogue-induced somatostatin receptor recruitment.

Authors:  B Draznin; J W Leitner; K E Sussman
Journal:  J Clin Invest       Date:  1985-05       Impact factor: 14.808

2.  Endogenous somatostatin-28 modulates postprandial insulin secretion. Immunoneutralization studies in baboons.

Authors:  J W Ensinck; R E Vogel; E C Laschansky; D J Koerker; R L Prigeon; S E Kahn; D A D'Alessio
Journal:  J Clin Invest       Date:  1997-11-01       Impact factor: 14.808

3.  A physiologic role for somatostatin 28 as a regulator of insulin secretion.

Authors:  D A D'Alessio; C Sieber; C Beglinger; J W Ensinck
Journal:  J Clin Invest       Date:  1989-09       Impact factor: 14.808

4.  Circulating prosomatostatin-derived peptides. Differential responses to food ingestion.

Authors:  J W Ensinck; E C Laschansky; R E Vogel; D A Simonowitz; B A Roos; B H Francis
Journal:  J Clin Invest       Date:  1989-05       Impact factor: 14.808

5.  Effect of caerulein administration on portal plasma somatostatin in dogs.

Authors:  J Kasanuki; S Fujimoto; H Makino; A Kanatsuka; T Imaizumi; H Koseki; R Kaneko; Y Tokumasa; S Yoshida
Journal:  Gastroenterol Jpn       Date:  1984-06

6.  Effect of somatostatin 14 on pure human pancreatic secretion.

Authors:  L Gullo; P Priori; C Scarpignato; F Baldoni; G Mattioli; L Barbara
Journal:  Dig Dis Sci       Date:  1987-10       Impact factor: 3.199

7.  Plasma somatostatin 28 increases in response to feeding in man.

Authors:  K S Polonsky; S E Shoelson; H M Docherty
Journal:  J Clin Invest       Date:  1983-05       Impact factor: 14.808

8.  Inhibitory effect of intragastric glucose on gastric acid secretion and gastric emptying of liquids in man. Role of endogenous somatostatin, gastrin, and insulin.

Authors:  H Sasaki; M Nagulesparan; A Dubois; B Vasquez; E Straus; M L Sievers; R H Unger
Journal:  Dig Dis Sci       Date:  1983-06       Impact factor: 3.199

9.  Plasma growth hormone-releasing hormone levels in type 1 (insulin-dependent) diabetic children following a mixed meal.

Authors:  R Rosskamp; F Haverkamp; B Thomas; J Klumpp
Journal:  Klin Wochenschr       Date:  1988-03-15

10.  Effect of somatostatin and thyrotropin-releasing hormone on cholecystokinin-induced gallbladder emptying.

Authors:  L Gullo; L Bolondi; C Scarpignato; P Priori; P Casanova; G Labò
Journal:  Dig Dis Sci       Date:  1986-12       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.